Skip to main content

Table 2 Comparison of biochemical data in blood and urine before and after treatment

From: Clinical, biochemical, and genetic analysis of 28 Chinese patients with holocarboxylase synthetase deficiency

 

C5-OH

(μmol/L)

C3

(μmol/L)

C3/C2

C5-OH/C3

Pyruvate

(mmol/mol Cr))

3-hydroxypropionate

(mmol/mol Cr)

3-hydroxyvaleric acid

(mmol/mol Cr))

3-methylcrotonylglycine

(mmol/mol Cr))

Methylcitric acid

(mmol/mol Cr))

Before treatment

(Median, range)

7.01

(3.26–15.01)

4.34

(0.61–14)

0.15

(0.03–0.63)

1.82

(0.12–11.59)

42.05

(4.52–990)

16.21

(4.07–470.3)

212.8

(7.5–550.4)

39.7

(8.54–177)

3.94

(0.9–42.24)

After treatment (Median, range)

0.35

(0.08–1.87)

1.64

(0.62–2.98)

0.08

(0.02–0.11)

0.27

(0.08–4.97)

2.32

(0.0–11.7)

0

(0.0–3.5)

1.1

(0.0–43.32)

1.01

(0.0–3.7)

0.17

(0.0–1.6)

P value

 < 0.001

0.007

0.007

0.028

0.013

0.025

 < 0.001

 < 0.001

0.004

Reference range

0.06–0.6

0.5–4.0

0.0–0.2

0.04–0.25

0.0–30.0

0.0–4.0

0.0–4.0

0.0–5.0

0.0–0.7